CRISPR-Cas12a-Based Biosensor for Rapid Detection of African Swine Fever Virus: From Assay Design to Field Deployment

1. Introduction

African swine fever virus (ASFV) is a large, double-stranded DNA virus that causes a highly contagious and often lethal hemorrhagic fever in domestic swine and wild boar [1, 19]. The virus belongs to the family Asfarviridae and is the sole member of the genus Asfivirus [20]. ASFV infection results in mortality rates approaching 100 percent in naive populations, and there is no commercially available vaccine or specific treatment [2, 3, 19]. Consequently, rapid and accurate detection of ASFV is critical for implementing timely quarantine measures and preventing large-scale outbreaks [1, 20]. Traditional diagnostic methods, such as virus isolation, enzyme-linked immunosorbent assay (ELISA), and quantitative real-time PCR (qPCR), are sensitive and specific but require centralized laboratory infrastructure, specialized equipment, and turnaround times of several hours to days [1, 22]. This limitation has driven the development of point-of-care (POC) alternatives suited for pen-side deployment [1, 19, 22].

Among emerging POC technologies, clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) protein systems have attracted considerable attention for nucleic acid detection [19]. In particular, Cas12a (formerly Cpf1) exhibits a unique trans-cleavage activity: upon specific recognition of a target DNA sequence by a CRISPR RNA (crRNA), the Cas12a nuclease non-specifically cleaves nearby single-stranded DNA (ssDNA) molecules [3, 18, 21]. This collateral cleavage property can be harnessed to generate detectable signals from fluorescent or colorimetric reporters, forming the basis of several diagnostic platforms, including DNA Endonuclease-Targeted CRISPR Trans Reporter (DETECTR) [18, 19] and Cas12a-based On-site and Rapid Detection System (CORDS) [4]. A recent comprehensive review of ASFV biosensors published between 2014 and 2025 identified 41 distinct devices and grouped them by receptor type (antibody, enzyme, or nucleic acid) and transduction mechanism (optical, mass-based, or electrochemical), with reported limits of detection ranging from 5 copies/μL for a CRISPR-Cas12a fluorescence assay to 0.5 ng/mL for a piezoelectric cantilever antigen sensor [1]. This literature underscored an urgent need for harmonized testing conditions and comparative field studies [1].

The present article provides an exhaustive, publication-grade review of CRISPR-Cas12a-based biosensors for ASFV detection, from fundamental assay design principles through to field deployment considerations. We cover target selection, guide RNA design, nuclease biochemistry, signal readout modalities, sample preparation, analytical performance, and challenges affecting translation from bench to pen-side. For complementary background on ASFV pathogenesis and transmission dynamics, readers are referred to the dedicated article on African Swine Fever Virus. A broader discussion of the platform technology is available in CRISPR-Cas12a and Cas13a Platforms for Rapid Veterinary Viral Diagnostics.

2. Principles of CRISPR-Cas12a-Based Detection

2.1 Target Selection in the ASFV Genome

Selecting an appropriate target gene is critical for assay specificity and coverage across ASFV genotypes. The ASFV genome is approximately 170 to 193 kbp in length and encodes more than 150 open reading frames [20]. Most CRISPR-Cas12a assays target the highly conserved p72 gene, which encodes the major capsid protein (B646L or B646L-like) [3, 4, 18]. The p72 gene is used by the World Organisation for Animal Health (WOAH) as a target for qPCR [3, 20]. Other conserved genomic sequences exploited for Cas12a detection include the D117L gene encoding the p17 structural protein [5], the KP177R gene encoding p22 [6], the E183L, K205R, and C962R genes [7], and the B646L region targeted in multiple studies [8, 9]. The diversity of targets allows redundancy: if new variants emerge with mutations in one primer or crRNA binding site, alternative targets can be deployed [3].

2.2 Guide RNA Design and Cas12a Activation

A functional CRISPR-Cas12a complex requires a crRNA that contains a 23 to 25 nucleotide spacer sequence complementary to the target DNA, adjacent to a short protospacer adjacent motif (PAM) sequence (typically 5'-TTTN-3' for Cas12a orthologs from Acidaminococcus or Lachnospiraceae) [3, 19]. The crRNA is synthesized by in vitro transcription or purchased as an oligonucleotide. After the crRNA guides Cas12a to the complementary DNA strand, the nuclease generates a double-strand break [9]. Subsequently, the Cas12a nuclease domain (RuvC) undergoes a conformational change that activates its non-specific ssDNA trans-cleavage activity [2, 21]. This collateral cleavage degrades any ssDNA molecule present in the reaction, including labeled reporter probes [2, 9]. The phenomenon is highly specific; single nucleotide mismatches in the seed region of the crRNA can abolish activation [9]. A 2019 study using a solution phase Cas12a assay achieved differentiation of nucleic acid targets with closely matched sequences [9]. In a systematic crRNA screen, 19 crRNAs targeting the p72 gene were evaluated, and several high-activity candidates were identified that could serve as alternatives if new variants emerge [3].

2.3 Signal Generation Mechanisms

The trans-cleavage signal can be transduced through several readout modalities:

Fluorescence readout. The most direct approach uses an ssDNA probe labeled with a fluorophore and a quencher at opposite ends. Upon Cas12a activation, the probe is cleaved, releasing the fluorophore from quenching, producing a measurable increase in fluorescence [9, 4]. This readout can be quantified using a fluorometer or a custom portable device [9]. In one study, a fluorescence-based CORDS system detected the p72 gene at femtomolar concentrations within one hour at 37 degrees Celsius [4].

Lateral flow biosensor (LFB) readout. For instrument-free visualization, the trans-cleavage activity can be coupled to a lateral flow strip. Typically, a biotin-labeled ssDNA reporter is used. Cleavage prevents the reporter from binding to the streptavidin line, altering the color development [10, 8]. Wu et al. combined PCR pre-amplification with Cas12a and a probe-based LFB to detect seven ASFV types with a sensitivity of 2.5 x 10^-15 M within 2 hours [10]. Zhang et al. used RPA-Cas12a-LFS targeting D117L and achieved a limit of detection of 2 gene copies with 100% coincidence with qPCR among 68 clinical samples [5].

Colorimetric readout. Several colorimetric strategies have been reported. One approach uses urease-conjugated ssDNA immobilized on magnetic beads. Activated Cas12a cleaves the ssDNA, releasing urease, which in turn hydrolyzes urea to ammonia, shifting the pH and producing a color change detectable by the naked eye [2]. Another method employs the G-quadruplex structure: Cas12a trans-cleavage degrades a G-rich ssDNA, preventing the formation of a catalytic G-quadruplex/hemin complex that otherwise oxidizes TMB to produce a green color [21].

Electrochemical readout. Li et al. coupled Cas12a with DNA nanoflowers (DNFs) prepared by rolling circle amplification. The Cas12a-crRNA complex was pre-conjugated onto the DNFs. Upon ASFV DNA binding, trans-cleavage degraded the DNFs, releasing DNA fragments and causing a large electrochemical signal change. This biosensor had a detection limit of 3.57 aM, three orders of magnitude lower than a conventional RCA-amplified sensor [17].

Table 1 summarizes representative CRISPR-Cas12a assays for ASFV detection, highlighting the target gene, amplification strategy, readout, and reported limits of detection.

Table 1. Representative CRISPR-Cas12a-Based ASFV Detection Assays

RPA: recombinase polymerase amplification; ERA: enzymatic recombinase amplification; LAMP: loop-mediated isothermal amplification; LFD: lateral flow dipstick; rxn: reaction.

3. Assay Workflow and Integration of Sample Preparation

A generic CRISPR-Cas12a detection workflow for ASFV involves (a) sample collection, (b) nucleic acid extraction (optional), (c) target amplification (optional), (d) Cas12a-crRNA recognition and trans-cleavage, and (e) signal readout. The following Mermaid diagram illustrates the typical decision tree.

flowchart TD
    A[Clinical sample: blood, oral fluid, tissue], > B[Sample lysis & nucleic acid release]
    B, > C{Amplification?}
    C, >|Yes: RPA, LAMP, PCR| D[Isothermal or thermal amplification<br>37-42°C, 20-30 min]
    C, >|No: amplification-free| E[Amplification-free Cas12a detection<br>~2 h, 1 pM LOD]
    D, > F[Cas12a-crRNA recognition<br>+ trans-cleavage of reporter]
    E, > F
    F, > G{Signal readout}
    G, > H[Fluorescence: fluorometer or portable reader]
    G, > I[Lateral flow: visual strip]
    G, > J[Colorimetric: pH change or G-quadruplex]
    G, > K[Electrochemical: electrode sensor]

3.1 Sample Collection and Nucleic Acid Purification

ASFV can be detected in whole blood, serum, oral fluids, and tissues [11, 16, 20]. Traditional nucleic acid extraction using column-based kits or organic solvents is time-consuming and requires laboratory equipment [1, 11]. To overcome this, several groups have developed simplified, field-compatible extraction methods. Qian et al. used cellulose filter paper dipsticks to purify nucleic acids from swine blood in 2 minutes, avoiding ethanol carryover and multiple pipetting steps. The dipstick-purified DNA was then used directly in a lyophilized LAMP-CRISPR assay, achieving a detection limit of 1 copy/μL within 50 minutes [11]. Similarly, Cao et al. described a non-nucleic-acid extraction method that allowed direct detection of ASFV from clinical samples using CRISPR-Cas12a, reducing total assay time and reagent costs [12].

Whole blood is a commonly submitted sample for ASFV surveillance. In a large field evaluation of an RPA-CRISPR assay using 102 suspect blood samples, the assay achieved 98.3% sensitivity and 100% specificity when processed through a simplified heating step rather than column purification [16]. Another study demonstrated that the CRISPR-Cas12a lateral flow dipstick could detect ASFV directly from whole blood without prior DNA extraction, using a simple boiling step [10, 5]. The dipstick-based LAMP-CRISPR approach described by Qian et al. integrated all steps from sample to result on a portable heating block and homemade fluorescence reader [11].

3.2 Isothermal Amplification Strategies

Most Cas12a assays incorporate an isothermal pre-amplification step to enhance sensitivity, as the inherent trans-cleavage rate limits direct detection to picomolar or femtomolar concentrations [9, 19]. The most frequently used amplification methods are RPA and LAMP. RPA operates at a constant temperature of 37-42 degrees Celsius and produces double-stranded amplicons that can be directly recognized by Cas12a-crRNA [4, 16, 18]. The combination of RPA and Cas12a (often called RPA-Cas12a or DETECTR) has been widely adopted [18]. In the CORDS platform, RAA (recombinase-aided amplification, a method similar to RPA) is paired with Cas12a and either fluorescence or lateral flow readout [4]. LAMP generates highly concatenated amplicons and is compatible with Cas12a detection when the target region is designed to be flanked by PAM sequences [11]. One-pot reactions that combine amplification and Cas12a cleavage in a single tube have been developed to simplify the workflow and reduce contamination risk [13].

4. Analytical Performance and Clinical Validation

4.1 Sensitivity and Specificity

CRISPR-Cas12a assays routinely achieve limits of detection in the range of 1 to 20 copies per reaction [5, 8, 7, 18]. When compared head-to-head with commercial qPCR kits or WOAH-recommended qPCR, the Cas12a-based assay showed approximately 10-fold higher sensitivity in one study [3]. In 149 clinical samples, the CRISPR/Cas12a-LFD method had 100% agreement with qPCR [8]. Similarly, the RPA-Cas12a DETECTR assay demonstrated 100% agreement (30/30) with qPCR in blood samples [18].

Specificity testing against a panel of other swine viruses (e.g., porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, classical swine fever virus, pseudorabies virus) has shown no cross-reactivity in multiple reports [5, 6, 7, 18]. In the study by Zhang et al., the p17-targeting strip did not cross-react with nine other swine viruses and achieved a coincidence rate of 100% with qPCR in 68 clinical samples [5]. The KP177R-based RPA-CRISPR/Cas12a assay also showed no cross-reaction with PCV2, PEDV, PDCoV, or PRV [6].

4.2 Comparison with qPCR and Other Assays

Quantitative real-time PCR remains the gold standard for ASFV detection, with high sensitivity and throughput [22]. However, qPCR requires expensive thermal cyclers, trained personnel, and significant turnaround time (typically 90-120 minutes excluding extraction) [3, 20]. In contrast, CRISPR-Cas12a assays can be completed in 30 to 60 minutes at a constant temperature, using inexpensive portable readers or even naked-eye readout [1, 19]. A direct comparison in the same laboratory demonstrated that the Cas12a assay was about 10 times more sensitive than the commercial qPCR kit for detecting ASFV p72 [3]. However, this performance advantage may depend on the specific assay design and sample matrix.

A comprehensive review of nucleic acid detection approaches for ASF highlighted that CRISPR-based methods offer a favorable trade-off among speed, cost, and field applicability [20]. For laboratory confirmation, qPCR remains indispensable; for screening and outbreak response, Cas12a biosensors provide a rapid and accessible alternative [19, 20].

5. Field Deployment and Point-of-Care Considerations

5.1 Portable Reader Integration

Fluorescence-based Cas12a assays require a light source and detector. Several groups have integrated custom, low-cost fluorometers that interface with disposable cartridges. He et al. developed a high-throughput, all-solution phase system using a custom fluorometer and achieved a detection limit of 100 fM after 24 hours incubation at physiological temperature [9]. The CORDS system utilized a simple incubator at 37 degrees Celsius and a lateral flow strip for visual readout, eliminating the need for electronic readers altogether [4]. Lyophilization of the RPA (or RAA) and Cas12a reagents into three tubes preserved activity for at least 7 days at 4 degrees Celsius, enabling long-term transport and field storage [4]. A subsequent optimization allowed the entire reaction to be carried out in a single tube containing lyophilized reagents, reducing the number of steps and potential for user error [13].

5.2 Sample-to-Answer Integration

Fully integrated sample-to-answer platforms remain a key goal. The dipstick-based nucleic acid purification approach [11] and the direct boiling methods [10, 16] represent progress toward eliminating the extraction bottleneck. However, most published studies still include a manual pipetting step for reagent mixing. Automation through microfluidic chips and lab-on-a-disc technologies is an active area of research [22]. The field-deployable paper-based biosensor described by Raut et al. (2026, preprint) targets whole blood detection without external instrumentation, but further validation is needed [14].

5.3 Challenges in Field Application

Despite promising laboratory results, several hurdles remain before widespread field deployment. First, cross-reactivity analyses against a broad panel of ASFV strains and genotypes are often incomplete; many studies tested only one or two genotypes [1]. Second, environmental stress testing (e.g., temperature fluctuations, humidity, inhibitor-rich matrices like feces or feed) is rarely reported [1]. Third, the visual readout of lateral flow strips is subjective and may require a reader for quantification in regulatory settings. Fourth, multiplexing capabilities (e.g., simultaneous detection of ASFV and other swine pathogens) are still limited, though proof-of-concept assays targeting ASFV and PCV2 have been developed [21]. A recent review noted that while CRISPR-Cas12a/13a diagnostics rival qPCR sensitivity, the reliance on nucleic acid extraction and the need for fully integrated "sample-in, result-out" systems must be addressed [19]. The adoption pathway may vary across production systems: as a sentinel tool in intensive settings, as a leapfrogging solution in rapidly intensifying regions, and through shared-service models in resource-limited contexts [19].

6. Future Directions

Ongoing innovations aim to further improve the sensitivity, specificity, and simplicity of CRISPR-Cas12a-based ASFV detection. Amplification-free methods, which rely on high-activity Cas12a variants or signal amplification cascades (e.g., using DNA nanoflowers [17] or hairpin reporters), could reduce assay time and eliminate the risk of amplicon contamination. The integration of CRISPR systems with biosensor transducers, such as electrochemical sensors [17], offers ultra-low detection limits (3.57 aM) and should be validated in field samples. Multiplex detection of ASFV alongside other emerging swine viral pathogens, such as porcine reproductive and respiratory syndrome virus, classical swine fever virus, and swine influenza A virus, would be valuable for differential diagnosis [7, 19, 22]. A dual-target approach for ASFV and PCV2 using G-quadruplex colorimetric readout has already been reported [21].

Furthermore, the use of locked nucleic acid (LNA) probes in biosensors has been shown to enhance stability and specificity for ASFV DNA detection [15]. Biagetti et al. developed a chimeric DNA/LNA probe targeting the conserved vp72 region, achieving a limit of detection of 178 copies/μL and reusability for up to 40 analyses per sensor surface [15]. Combining such robust probe chemistries with CRISPR-Cas12a trans-cleavage could yield even more resilient pen-side tests.

Computational tools for guide RNA design and for predicting off-target effects are critical for ensuring assay specificity across diverse ASFV isolates [3, 19]. Readers interested in bioinformatic aspects are referred to Guide RNA Design Algorithms for CRISPR Systems and a discussion on Computational Modeling of Veterinary Virus Spread based on Diagnostic Data. The role of Biosensors and Point-of-Care (POC) Veterinary Diagnostics is further elaborated in a related site article.

7. Conclusion

CRISPR-Cas12a-based biosensors represent a transformative approach for rapid, field-deployable detection of ASFV. The combination of programmable target recognition, collateral trans-cleavage activity, and diverse readout modalities allows sensitive and specific detection within 30 to 60 minutes using simple instrumentation. Assays have been validated across multiple ASFV genes (p72, D117L, KP177R, E183L, K205R, C962R) and in various clinical samples, including whole blood, oral fluids, and tissues. Although challenges remain in standardization, multiplexing, extraction-free detection, and regulatory validation, the technology is poised to fill a critical gap in swine disease surveillance and outbreak control. Continued research into lyophilized one-pot reactions, integrated microfluidic platforms, and robust field validation will accelerate the translation of CRISPR-Cas12a biosensors from academic prototypes to essential tools in the veterinary diagnostic arsenal.

References

[1] Boodoo C, Alocilja E. Biosensor Strategies for Rapid African Swine Fever Virus Detection. ACS Omega. 2025. https://www.semanticscholar.org/paper/033be3ed8e5459623f93543662b424eceefae3c0

[2] Ki J, Na H-K, Yoon S-W, et al. CRISPR/Cas-Assisted Colorimetric Biosensor for Point-of-Use Testing for African Swine Fever Virus. ACS Sensors. 2022. https://www.semanticscholar.org/paper/68e33e8efb92eeebb8e30eb1a8d024f0398a77dc

[3] Wang X, He S-D, Zhao N, et al. Development and clinical application of a novel CRISPR-Cas12a based assay for the detection of African swine fever virus. BMC Microbiol. 2020. https://www.semanticscholar.org/paper/caa9a7b8380d58efb484c0ccd50fdd3f472ef6de

[4] Bai J, Lin H, Li H, et al. Cas12a-Based On-Site and Rapid Nucleic Acid Detection of

[5] Zhang D, Jiang S, Xia N, et al. Rapid Visual Detection of African Swine Fever Virus with a CRISPR/Cas12a Lateral Flow Strip Based on Structural Protein Gene D117L. Animals. 2023. https://www.semanticscholar.org/paper/ddf6308c9fc8a5569195ccc2739772a4b3bddfee

[6] Luan H, Wang S, Ju L, et al. KP177R-based visual assay integrating RPA and CRISPR/Cas12a for the detection of African swine fever virus. Front Immunol. 2024. https://www.semanticscholar.org/paper/ca02bd4ef72391f0e5131250e2e26d8f91e00753

[7] Cao S, Ma D, Xie J, et al. Point-of-care testing diagnosis of African swine fever virus by targeting multiple genes with enzymatic recombinase amplification and CRISPR/Cas12a System. Front Cell Infect Microbiol. 2024. https://www.semanticscholar.org/paper/cb3b3ef42872b5112f6e92e46ff621b62d97c613

[8] Wang X, Ji P, Fan H, et al. CRISPR/Cas12a technology combined with immunochromatographic strips for portable detection of African swine fever virus. Commun Biol. 2020. https://www.semanticscholar.org/paper/b9b0bde3115cf860138332d6f1249a1741da86c2

[9] He Q, Yu D, Bao M, et al. High-throughput and all-solution phase African Swine Fever Virus (ASFV) detection using CRISPR-Cas12a and fluorescence based point-of-care system. bioRxiv. 2019. https://www.semanticscholar.org/paper/802208db7d6987403c98e163a52452786f44d5ac

[10] Wu J, Mukama O, Wu W, et al. A CRISPR/Cas12a Based Universal Lateral Flow Biosensor for the Sensitive and Specific Detection of African Swine-Fever Viruses in Whole Blood. Biosensors. 2020. https://www.semanticscholar.org/paper/016bccc00bc689aaa0183ee5ed900d76451f61fb

[11] Qian S, Chen Y, Peng C, et al. Dipstick-based rapid nucleic acids purification and CRISPR/Cas12a-mediated isothermal amplification for visual detection of African swine fever virus. Talanta. 2022. https://www.semanticscholar.org/paper/16567f5cf973020c6b239e37f415471311d81291

[12] Cao G, Xiong Y, Nie F, et al. Non-nucleic acid extraction and ultra-sensitive detection of African swine fever virus via CRISPR/Cas12a. Appl Microbiol Biotechnol. 2022. https://www.semanticscholar.org/paper/60a0a6a7de7b258029296cb4ee326b356541e556

[13] Gao X, Dong X, Song H, et al. A one-pot CRISPR-Cas12a-based assay for rapid, on-site detection of African swine fever virus. Int J Biol Macromol. 2025. https://www.semanticscholar.org/paper/f745d021a5aa6f1a92b4a6ad978afa17cdbe2b95

[14] Raut B, Palla G, Rafiq N, et al. A rapid, field-deployable paper-based biosensor for the detection of African swine fever virus in whole blood. bioRxiv. 2026. https://www.semanticscholar.org/paper/41443a00b71b95601498c21098c07b540e098325

[15] Biagetti M, Cuccioloni M, Bonfili L, et al. Chimeric DNA/LNA-based biosensor for the rapid detection of African swine fever virus. Talanta. 2018. https://www.semanticscholar.org/paper/0ff3f08ad7754346a29f83227c2f41b720083b9a